Schwan: Roche to pursue 'targeted acquisitions'

Roche isn't pursuing any large deals, especially ones the size of Abbott Labs' ($ABT) recently announced overhaul, CEO Severin Schwan (photo) said in an interview. "We are not interested in mega-mergers. We are interested in very targeted acquisitions which complement our technologies and portfolios," he explained. News